Sun Yan
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Toripalimab Plus TPF Chemotherapy and Radiotherapy for LA-HPSCC (NCT04624308) | Sun Yan | 2020-10-30 |
| Second-Line Chemotherapy Combined With Endostatin for Recurrent/Metastatic HN Epithelial Tumors (NCT03989830) | Sun Yan | 2019-07-29 |
Track Sun Yan automatically
Every clearance here is in the API, with alerts when new ones post.